首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   41832篇
  免费   3353篇
  国内免费   2440篇
  2024年   60篇
  2023年   484篇
  2022年   1135篇
  2021年   1969篇
  2020年   1225篇
  2019年   1506篇
  2018年   1410篇
  2017年   1087篇
  2016年   1624篇
  2015年   2429篇
  2014年   2856篇
  2013年   3097篇
  2012年   3597篇
  2011年   3402篇
  2010年   1951篇
  2009年   1799篇
  2008年   2093篇
  2007年   1876篇
  2006年   1605篇
  2005年   1426篇
  2004年   1202篇
  2003年   1054篇
  2002年   908篇
  2001年   854篇
  2000年   742篇
  1999年   716篇
  1998年   435篇
  1997年   464篇
  1996年   441篇
  1995年   390篇
  1994年   378篇
  1993年   308篇
  1992年   441篇
  1991年   383篇
  1990年   331篇
  1989年   246篇
  1988年   236篇
  1987年   198篇
  1986年   141篇
  1985年   185篇
  1984年   121篇
  1983年   104篇
  1982年   80篇
  1981年   60篇
  1980年   55篇
  1979年   72篇
  1978年   66篇
  1977年   46篇
  1976年   48篇
  1973年   48篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
The objective of this study was to determine whether a fragment(s) of type II collagen can induce cartilage degradation. Fragments generated by cyanogen bromide (CB) cleavage of purified bovine type II collagen were separated by HPLC. These fragments together with selected overlapping synthetic peptides were first analysed for their capacity to induce cleavage of type II collagen by collagenases in chondrocyte and explant cultures of healthy adult bovine articular cartilage. Collagen cleavage was measured by immunoassay and degradation of proteoglycan (mainly aggrecan) was determined by analysis of cleavage products of core protein by Western blotting. Gene expression of matrix metalloproteinases MMP-13 and MMP-1 was measured using Real-time PCR. Induction of denaturation of type II collagen in situ in cartilage matrix with exposure of the CB domain was identified with a polyclonal and monoclonal antibodies that only react with this domain in denatured but not native type II collagen. As well as the mixture of CB fragments and peptide CB12, a single synthetic peptide CB12-II (residues 195-218), but not synthetic peptide CB12-IV (residues 231-254), potently and consistently induced in explant cultures at 10 microM and 25 microM, in a time, cell and dose dependent manner, collagenase-induced cleavage of type II collagen accompanied by upregulation of MMP-13 expression but not MMP-1. In isolated chondrocyte cultures CB12-II induced very limited upregulation of MMP-13 as well as MMP-1 expression. Although this was accompanied by concomitant induction of cleavage of type II collagen by collagenases, this was not associated by aggrecan cleavage. Peptide CB12-IV, which had no effect on collagen cleavage, clearly induced aggrecanase specific cleavage of the core protein of this proteoglycan. Thus these events involving matrix molecule cleavage can importantly occur independently of each other, contrary to popular belief. Denaturation of type II collagen with exposure of the CB12-II domain was also shown to be much increased in osteoarthritic human cartilage compared to non-arthritic cartilage. These observations reveal that peptides of type II collagen, to which there is increased exposure in osteoarthritic cartilage, can when present in sufficient concentration induce cleavage of type II collagen (CB12-II) and aggrecan (CB12-IV) accompanied by increased expression of collagenases. Such increased concentrations of denatured collagen are present in adult and osteoarthritic cartilages and the exposure of chondrocytes to the sequences they encode, either in soluble or more likely insoluble form, may therefore play a role in the excessive resorption of matrix molecules that is seen in arthritis and development.  相似文献   
992.
镉对雄性小鼠生精细胞的影响   总被引:1,自引:0,他引:1  
为了研究镉对小鼠生殖力和生精细胞的作用,本文对氯化镉处理后的雄性小鼠进行了交配实验,以观察其对怀孕率、每窝产仔数及子代性比的影响。测定比较了注射镉后,小鼠成熟精子的总LDH酶和LDH-X酶的活性;还用双向电泳方法分析了成熟精子的蛋白质变化。结果表明,处理组在怀孕率、每窝产仔数及子代性比方面无统计学意义的差异。成熟精子的总LDH活性经镉处理后未发现明显变化,但镉能显著地抑制与精子运动的能量有关的LDH-X酶的活性。双向电泳图谱表示,镉处理后,精子中含量较少的三组蛋白质或消失不见,或发生明显变化。  相似文献   
993.
高效溶磷菌的分离、筛选及在土壤中溶磷有效性的研究   总被引:11,自引:0,他引:11  
从采自全国各地130个土样中.分离出1000余菌株,从中筛选出1株代号为Ap-2号的高效溶磷菌.经鉴定为黑曲霉Aspergillus niger.对该菌株的产酸特性以及接种土壤后的溶磷有效性进行了研究.试验表明,该菌株发酵过程产草酸、柠檬酸等多种有机酸,使土壤速效磷含量增加141.94%.其溶磷作用,与土壤pH含水量有密切关系,对温度要求不严,与接种量是一定正相关.并可与磷酸铵、三料、尿素、硫酸铵等化肥混合使用.  相似文献   
994.
根瘤细胞早期发育阶段,以宿主细胞器和根瘤菌转化类菌体的数量增多为特征。随后类菌体增殖到填满宿主细胞内的大部分区域。各个类菌体周膜内含有1至几个类菌体。晚期共生发育阶段,类菌体细胞结构和宿主细胞器数量发生了变化。文中还讨论了根瘤的共生固氮作用。  相似文献   
995.
植物重要功能基因研究进展及其应用   总被引:1,自引:0,他引:1  
吴健  刘学  王永红 《生命科学》2011,(2):168-178
随着越来越多植物全基因组测序的完成,植物基因研究的重点将逐渐从基因的发现转移到对基因功能的研究上来。近年来,植物基因功能的阐述日益深入,尤其是与作物产量和抗性相关的重要农艺性状调控机理的研究更加引人注目,一些具有应用价值的功能基因相继被鉴定并得到功能注释。该文综述植物功能基因研究领域近年来的主要进展,着重介绍具有应用前景的重要功能基因的研究。同时,对目前利用基因工程、分子标记辅助选择等于段改良作物的现状及其前景进行讨论。  相似文献   
996.
应用响应面法对一株粘性嗜热链球菌ST-1的产胞外多糖的发酵条件进行了优化.根据单因素的实验结果,选取接种量,发酵温度,发酵时间作为考察因素,以胞外多糖的产量作为响应值,利用Box-Behnken实验设计方法,建立了胞外多糖产量与三个考察因素之间的回归方程并得到最佳发酵条件为:接种量5%,发酵时间14 h,发酵温度42℃...  相似文献   
997.
998.
Recently, miR-22 was found to be differentially expressed in different skeletal muscle growth period, indicated that it might have function in skeletal muscle myogenesis. In this study, we found that the expression of miR-22 was the most in skeletal muscle and was gradually up-regulated during mouse myoblast cell (C2C12 myoblast cell line) differentiation. Overexpression of miR-22 repressed C2C12 myoblast proliferation and promoted myoblast differentiation into myotubes, whereas inhibition of miR-22 showed the opposite results. During myogenesis, we predicted and verified transforming growth factor beta receptor 1 (TGFBR1), a key receptor of the TGF-β/Smad signaling pathway, was a target gene of miR-22. Then, we found miR-22 could regulate the expression of TGFBR1 and down-regulate the Smad3 signaling pathway. Knockdown of TGFBR1 by siRNA suppressed the proliferation of C2C12 cells but induced its differentiation. Conversely, overexpression of TGFBR1 significantly promoted proliferation but inhibited differentiation of the myoblast. Additionally, when C2C12 cells were treated with different concentrations of transforming growth factor beta 1 (TGF-β1), the level of miR-22 in C2C12 cells was reduced. The TGFBR1 protein level was significantly elevated in C2C12 cells treated with TGF-β1. Moreover, miR-22 was able to inhibit TGF-β1-induced TGFBR1 expression in C2C12 cells. Altogether, we demonstrated that TGF-β1 inhibited miR-22 expression in C2C12 cells and miR-22 regulated C2C12 cell myogenesis by targeting TGFBR1.  相似文献   
999.
Vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen, can act in tumor-induced angiogenesis by binding to specific receptors on the surface of endothelial cells. One such receptor, VEGFR-2/KDR, plays a key role in VEGF-induced angiogenesis. Here, we expressed the catalytic domain of VEGFR-2 as a soluble active kinase using Bac-to-Bac expression system, and investigated correlations between VEGFR-2 activity and enzyme concentration, ATP concentration, substrate concentration and divalent cation type. We used these data to establish a convenient, effective and non-radioactive ELISA screening technique for the identification and evaluation of potential inhibitors for VEGFR-2 kinase. We screened 200 RTK target-based compounds and identified one (TKI-31) that potently inhibited VEGFR-2 kinase activity (IC50=0.596 microM). Treatment of NIH3T3/KDR cells with TKI-31 blocked VEGF-induced phosphorylation of KDR in a dose-dependent manner. Moreover, TKI-31 dose-dependently suppressed HUVEC tube formation. Thus, we herein report a novel, efficient method for identifying VEGFR-2 kinase inhibitors and introduce one, TKI-31, that may prove to be a useful new angiogenesis inhibitor.  相似文献   
1000.
ochotonidaeThomas,l897AlloptoxDaw8on,l96lAlloptoxsihongensis8p.nov.(Figs.lAi6)HolotypeArightp3,V884o.7.Paratypesldp3,V884o.l;3p3,V884o.3,5,6;1p4,V884O.9;2ml/m2,V884o.l2,16;Afragmentof1eftmandiblewithp4,V884O.l8;thefrontpartofrightman-diblewithi2,p3-p4,V884o.24;2I2,V884O.21,23;4P3,V884O-31-33,56;P4,V884o.27;AfragmentofleftupperjawwithP3-M1,V884o-57;2M2,V884o.5o,53.TypelocalityS0nglinzhuang,Sih0ngC0unty,Jiangsu.StratumtypicumandageXiaca0wanFormation,.EarIyMi0cene(Shan-wangian),eq…  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号